Cancer Research UK
Clinical Trials Unit Glasgow
 
 
 

Study Title: PIONEER

Study Description: A Phase I Study of Olaparib in Combination with Chemo-radiation in Locally Advanced Pancreatic Cancer

Study Design: Phase I, Open Label, Non-randomised, Multi-Centre.

Trial Status: Open to recruitment

Chief Investigator: Professor Jeff Evans

Sponsor: Greater Glasgow & Clyde Health Board and The University of Glasgow

Date Opened: 8th July 2015

Planned Closure Date:

Target Recruitment: 18-42

Open to New Sites: No

Contact Details:

Clinical Trials Unit, Glasgow (CTUG)
Liz-Anne Lewsley/Avril Trevethan
CRUK CTU, Glasgow
E-mail: liz-anne.lewsley@glasgow.ac.uk, avril.trevethan@glasgow.ac.uk

Click here to download the Initiation Slides

For queries concerning Pharmacovigilance, or the documents to refer to for the clinical management of trial patients or those that are acting as the Reference Safety Information please contact:

The Pharmacovigilance Team email: mvls-ctu-pv@glasgow.ac.uk or
Telephone: 00141 211 0352/0203/3567/3968 or 0141 232 2068

Version of NCI Common Terminology Criteria for Adverse Events (CTCAE) being used for the study (if applicable): 4.03

Click here to download the CTCAE